“called Trazodone. Trazodone was originally developed as an antidepressant approved at doses of 300 milligrams for major depressive disorder. But approximately half of the patients taking Trazodone for depression develop excessive daytime sleepiness compared to 19% of those receiving a placebo.”
Discussed